The publicly listed company Pharma Aids has released its unaudited financial report for the first quarter ending September 30, 2025.
According to company sources, in the first quarter (July–September 2025), the company’s earnings per share (EPS) stood at Tk 6.81, compared to Tk 5.66 during the same period last year.
At the end of the reporting quarter, the company’s net operating cash flow per share (NOCFPS) stood at Tk 8.87, which was Tk 0.43 during the same period last year.
As of September 30, 2025, the company’s net asset value per share (NAVPS) was Tk 145.32.
